Use of biologic agents and methotrexate improves renal manifestation and outcome in patients with rheumatoid arthritis: a retrospective analysis

被引:0
作者
Masato Sawamura
Naoki Sawa
Masayuki Yamanouchi
Daisuke Ikuma
Akinari Sekine
Hiroki Mizuno
Masahiro Kawada
Rikako Hiramatsu
Noriko Hayami
Eiko Hasegawa
Tatsuya Suwabe
Junichi Hoshino
Kei Kono
Keiichi Kinowaki
Kenichi Ohashi
Yutaka Yamaguchi
Yoshifumi Ubara
机构
[1] Toranomon Hospital,Nephrology Center and Department of Rheumatology
[2] Toranomon Hospital,Department of Pathology
[3] Toranomon Hospital,Okinaka Memorial Institute for Medical Research
[4] Tokyo Medical and Dental University,Department of Human Pathology
[5] Yamaguchi’s Pathology Laboratory,Nephrology Center
[6] Toranomon Hospital,undefined
来源
Clinical and Experimental Nephrology | 2022年 / 26卷
关键词
Rheumatoid arthritis; Renal manifestation; AA-Amyloidosis; IgA nephropathy; Membranous nephropathy; Nephrosclerosis; Disease-modifying antirheumatic drugs (DMARDs); Biologic agent;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:341 / 349
页数:8
相关论文
共 133 条
[1]  
Helin HJ(1995)Renal biopsy findings and clinicopathologic correlations in rheumatoid arthritis Arthritis Rheum 38 242-247
[2]  
Korpela MM(1998)Analysis of renal pathology and drug history in 158 Japanese patients with rheumatoid arthritis Clin Nephrol 50 154-160
[3]  
Mustonen JT(2010)2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Arthritis Rheum 62 2569-2581
[4]  
Pasternack AI(2009)Revised equations for estimating glomerular filtration rate (GFR) from serum creatinine in Japan Am J Kidney Dis 53 982-992
[5]  
Nakano M(2014)Membranoproliferative glomerulonephritis and circulating cryoglobulins Clin Exp Nephrol 18 88-94
[6]  
Ueno M(2002)Bucillamine induces membranous glomerulonephritis Am J Kidney Dis 39 706-712
[7]  
Nishi S(2006)Outcome and treatment of bucillamine-induced nephropathy Nephron Clin Pract 104 c15-c19
[8]  
Shimada H(1990)Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients Ann Rheum Dis 49 363-369
[9]  
Hasegawa H(2012)Treatment with biologic agents improves the prognosis of patients with rheumatoid arthritis and amyloidosis J Rheumatol 39 1348-1354
[10]  
Watanabe T(2015)Analysis of 65 renal biopsies from patients with rheumatoid arthritis (1976–2015): change in treatment strategies decreased frequency and modified histopathological findings J Clin Rheumatol 21 335-340